EMEA-001142-PIP02-16-M02 - paediatric investigation plan

ceftolozane
tazobactam
PIPHuman

Hungarian is available via eTranslation, the European Commission's machine translation service.

Translate to Hungarian | Important information about machine translation

Key facts

Invented name
Zerbaxa
Active substance
  • ceftolozane
  • tazobactam
Therapeutic area
Infections and infestations
Decision number
P/0381/2024
PIP number
EMEA-001142-PIP02-16-M02
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of pneumonia
Route(s) of administration
Intravenous use
Contact for public enquiries

Merck Sharp & Dohme B.V.
E-mail: pip.information@msd.com 
Tel.:  +33 180464738

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date
Compliance check done
Nem

Decision

Share this page